For the quarter ending 2025-09-30, BDSX made $21,768K in revenue. -$8,716K in net income. Net profit margin of -40.04%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenues | 21,768 | 20,018 | 17,958 | 17,724 |
| Direct costs and expenses | 4,106 | 4,031 | 3,703 | 3,798 |
| Research and development | 2,992 | 3,269 | 2,870 | 2,337 |
| Sales, marketing, general and administrative | 21,714 | 22,411 | 20,448 | 20,145 |
| Impairment loss on intangible assets | 7 | 26 | 73 | 60 |
| Total operating expenses | 28,819 | 29,737 | 27,094 | 26,360 |
| Loss from operations | -7,051 | -9,719 | -9,136 | -8,636 |
| Other income , net | - | - | - | 18 |
| Interest expense | 2,074 | 1,898 | 1,685 | 1,933 |
| Loss on extinguishment of liabilities | - | - | - | -62 |
| Change in fair value of warrant liability, net | - | -98 | 378 | - |
| Other income (expense), net | 409 | 51 | 98 | - |
| Total other expense | -1,665 | -1,749 | -1,965 | -2,255 |
| Net loss | -8,716 | -11,468 | -11,101 | -10,891 |
| Earnings per share, basic, total | -1.16 | -0.08 | -0.08 | -0.087 |
| Earnings per share, diluted, total | -1.16 | -0.08 | -0.08 | -0.087 |
| Weighted average number of shares outstanding, basic, total | 7,500,000 | 146,656,000 | 146,547,000 | -5,542,000 |
| Weighted average number of shares outstanding, diluted, total | 7,500,000 | 146,656,000 | 146,547,000 | -5,542,000 |
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)